Back to Trades
Yocca Frank
Chief Scientific OfficerCIK 0001733272
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 1
- Active
- 2025–2026
Across 9 filings between 2025–2026, Yocca Frank, Chief Scientific Officer, has disclosed $7.4K in transactions — all concentrated in BioXcel Therapeutics, Inc. (BTAI). Their disclosed trades are heavily weighted toward selling — $0 in buys and $7.4K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jun 17 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Exercise | $0 |
| May 22 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Sell | $7.4K |
| May 7 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Exercise | $0 |
| Mar 16 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Exercise | $0 |
| Jan 5 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Award | $0 |
| Dec 15 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Exercise | $0 |
| Sep 16 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Exercise | $0 |
| Aug 5 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Award | $0 |
| Jul 22 | BTAI BioXcel Therapeutics, Inc. | Yocca Frank | Chief Scientific Officer | Grant | $0 |
9 filings